These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7049360)

  • 21. Antitumor effect of electrochemical therapy on transplantable mouse cancers.
    Wójcicki M; Droździk M; Olewniczak S; Opolski A; Wietrzyk J; Radzikowski C; Kaczmarek B; Wrzesiński M; Romanowski M; Kamiński M; Zieliński S
    Med Sci Monit; 2000; 6(3):498-502. PubMed ID: 11208360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of BR96 sFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinoma.
    Henry CJ; Buss MS; Hellström I; Hellström KE; Brewer WG; Bryan JN; Siegall CB
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):751-5. PubMed ID: 15701865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumoricidal response induced by cytosine arabinoside after plasma perfusion over protein A.
    Terman DS; Yamamoto T; Tillquist RL; Henry JF; Cook GL; Silvers A; Shearer WT
    Science; 1980 Sep; 209(4462):1257-9. PubMed ID: 7403885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model.
    Emtage PC; Wan Y; Bramson JL; Graham FL; Gauldie J
    J Immunol; 1998 Mar; 160(5):2531-8. PubMed ID: 9498799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.
    Mistry B; Kimmel PL; Hetzel PC; Phillips TM; Braden GL
    Am J Kidney Dis; 2004 Oct; 44(4):e50-8. PubMed ID: 15384034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor growth inhibition by protein A and non-protein A containing Staphylococcus aureus in a mouse mammary carcinoma model.
    Langvad E; Espersen F; Briand P
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):255-9. PubMed ID: 6516852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of Protein-A in the treatment of malignancy: rationale and the NCI experience.
    Messerschmidt GL; Bowles C; Parrillo J; Parker M; Shelhammer J; Dowling R; Osborne L; Corbitt R; McCormack K; Longo D; Deisseroth A
    Prog Clin Biol Res; 1982; 106():385-90. PubMed ID: 6757952
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of canine transmissible venereal tumor by intravenous administration of protein A.
    Cohen D; Fer MF; Pearson JW; Herberman RB
    J Biol Response Mod; 1984; 3(3):271-7. PubMed ID: 6747669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM; Lopez DM
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
    Reilly RT; Gottlieb MB; Ercolini AM; Machiels JP; Kane CE; Okoye FI; Muller WJ; Dixon KH; Jaffee EM
    Cancer Res; 2000 Jul; 60(13):3569-76. PubMed ID: 10910070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal immunoadsorption of plasma from a metastatic colon carcinoma patient by protein A-containing nonviable Staphylococcus aureus: clinical, biochemical, serologic, and histologic evaluation of the patient's response.
    Ray PK; Idiculla A; Mark R; Rhoads JE; Thomas H; Bassett JG; Cooper DR
    Cancer; 1982 May; 49(9):1800-9. PubMed ID: 7074582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein.
    Wu X; He Y; Falo LD; Hui KM; Huang L
    Mol Ther; 2001 Mar; 3(3):368-74. PubMed ID: 11273779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma.
    Bruckheimer E; Harvie P; Orthel J; Dutzar B; Furstoss K; Mebel E; Anklesaria P; Paul R
    Cancer Gene Ther; 2004 Feb; 11(2):128-34. PubMed ID: 14671672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET; Kelley M; Rockwell S
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.
    Allione A; Consalvo M; Nanni P; Lollini PL; Cavallo F; Giovarelli M; Forni M; Gulino A; Colombo MP; Dellabona P
    Cancer Res; 1994 Dec; 54(23):6022-6. PubMed ID: 7954438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor.
    Sabel MS; Arora A; Su G; Chang AE
    Cryobiology; 2006 Dec; 53(3):360-6. PubMed ID: 16973145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
    Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
    Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer.
    Shih LB; Xuan H; Aninipot R; Stein R; Goldenberg DM
    Cancer Res; 1995 Dec; 55(23 Suppl):5857s-5863s. PubMed ID: 7493360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.